thelancet.com
Safety, tolerability and clinical effects of rovunaptabin, also known as BC007 on fatigue and quality of life in patients with Post-COVID syndrome (reCOVer): a prospective, exploratory, placebo-contro...
As this proof-of-concept study showed effects on the patient-centred endpoint PCS
and a good safety profil, subsequent studies are needed to confirm these results in
a larger cohort.